-
Novavax Providing 1.1B Vaccine Doses to Global Group
Novavax, developer of a vaccine to prevent Covid-19 disease, is providing 1.1 billion doses of its vaccine for distribution to lower resource regions.
-
Crispr-Edited Bananas Get Industry Funding
A popular type of banana, genetically edited to resist a soil fungus that threatens this fruit worldwide, is now backed by a major American food brand.
-
New Funds Backing Global Health, Early-Stage Ventures
Three new funds are financing start-up companies creating solutions for health issues in less-developed countries and early-stage life science businesses.
-
Photo Algorithms Find Cancerous Melanoma Lesions
An engineering team designed artificial intelligence techniques with image analysis to identify early signs of skin cancer in ordinary photographs.
-
Turn Your Business Into an International Organism
One of the most exciting prospects you might want to consider is to try going international.
-
Novartis, Gates Partner on Sickle Cell Gene Therapy
Global drug maker Novartis is collaborating with the Bill and Melinda Gates Foundation to find affordable gene therapies for sickle cell disease.
-
Wearable Sensor Patch Records Multiple Health Measures
An engineering team developed a transparent thin film sensor patch that measures several vital signs for monitoring heart disease and diabetes.
-
AI Cell Analysis Start-Up Raises $6M Seed Funds
A new enterprise using artificial intelligence to analyze individual cells for immune-related diagnostics and therapies is raising $6 million in seed funds.
-
Grant Funds Brain Disease Tissue Banks
An advocacy organization for neurodegenerative diseases and medical research foundation are sponsoring formation of a network to collect brain tissue samples.
-
Infographic – States Reporting SARS-CoV-2 Variants
The most widespread variant so far in the U.S. is B.1.1.7, first discovered in the U.K.